Effectiveness of a Prostacyclin IP Receptor Agonist in Patients With Pulmonary Arterial Hypertension in the Real-world Andalusian Setting: The RAMPHA Study
R Bravo-Marqués, V Becerra-Muñoz… - Clinical Therapeutics, 2024 - Elsevier
Purpose The pillar for therapeutic decisions in the evolution of pulmonary arterial
hypertension (PAH) is the patients' prognostic stratification. Methods A retrospective cohort …
hypertension (PAH) is the patients' prognostic stratification. Methods A retrospective cohort …